COMPANY NEWS


Caplin Point Laboratories Ltd
BSE Code 524742 ISIN Demat INE475E01026 Book Value (₹) 183.05 NSE Symbol CAPLIPOINT Div & Yield % 0.19 Market Cap ( Cr.) 10,164.80 P/E * 35.83 EPS * 37.36 Face Value (₹) 2
* Profit to Earning Ratio
* Earning Per Share
Caplin Steriles receives USFDA approval for Ofloxacin Otic Solution Back
(08 Jan 2024)
Caplin Steriles (Caplin), a subsidiary company of Caplin Point Laboratories has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ofloxacin Otic Solution 0.3%, a generic therapeutic equivalent version of (RLD), FLOXIN Otic Solution of Daiichi Pharmaceuticals Inc.

Ofloxacin Otic Solution 0.3% is used as anti-infective (antibacterial) for otic (ear) use.

According to IQVIATM (IMS Health), Ofloxacin Otic Solution 0.3% had US sales of approximately $36 million for the 12-month period ending June 2023.